Ohnuma T, Szrajer L, Holland J F, Kurimoto M, Minowada J
Department of Neoplastic Diseases, Mount Sinai Medical Center, New York, NY 10029.
Cancer Immunol Immunother. 1993;36(1):31-6. doi: 10.1007/BF01789128.
Effects of human natural interferon alpha (nIFN) alone, human natural tumor necrosis factor alpha (nTNF) alone and their combination (OH-1) were tested on three human mesothelioma lines implanted in nude mice. Tumors were transplanted subcutaneously by trocar on treatment day -12. nIFN was given intraperitoneally (i.p.) at a dose of 2 x 10(7) or 2 x 10(8) IU kg-1 day-1, 5 days a week for 3 weeks. nTNF was given i.p. at a dose of 2 x 10(7) or 2 x 10(8) U kg-1 day-1 in the same schedule as that of nIFN. Tumor diameters were serially measured and tumor volumes were calculated. Antitumor effects were assessed by two methods: comparison of final tumor volumes in treated and control groups (T/C), and changes in median average total tumor volume. The treatment produced no clinically discernible toxicities. nIFN had strong inhibitory activity against all three human mesothelioma lines. nTNF alone had modest activity only at the high dose used. The combination of the two produced activity essentially similar to that produced by nIFN alone. High-dose nIFN may have a role as an active agent in the treatment of patients with mesothelioma.
分别对单独使用人天然α干扰素(nIFN)、单独使用人天然α肿瘤坏死因子(nTNF)及其组合(OH - 1)在植入裸鼠体内的三种人恶性间皮瘤细胞系上的效果进行了测试。在治疗第 - 12天,通过套管针将肿瘤皮下移植。nIFN以2×10⁷或2×10⁸IU kg⁻¹天⁻¹的剂量腹腔内注射(i.p.),每周5天,共3周。nTNF以与nIFN相同的给药方案,按2×10⁷或2×10⁸U kg⁻¹天⁻¹的剂量腹腔内注射。连续测量肿瘤直径并计算肿瘤体积。通过两种方法评估抗肿瘤效果:比较治疗组和对照组的最终肿瘤体积(T/C)以及平均总肿瘤体积中位数的变化。该治疗未产生临床上可察觉的毒性。nIFN对所有三种人恶性间皮瘤细胞系均具有强烈的抑制活性。单独使用nTNF仅在所用高剂量时有适度活性。两者的组合产生的活性与单独使用nIFN产生的活性基本相似。高剂量nIFN可能在恶性间皮瘤患者的治疗中作为一种活性剂发挥作用。